Differential scanning calorimetry investigation of crystallization kinetics and glass-forming ability of sulfonamides
Source abstract
Abstract
Robust determination of the parameters governing the stability of the amorphous drugs is one of the key tasks of modern pharmaceutics. The kinetic stability of such systems is of crucial importance, as it affects their practical applications. In the present work we have determined the critical cooling rates, and the kinetic parameters of the cold crystallization of four slowly crystallizing sulfonamides, i.e. sulfaguanidine, sulfapyridine, sulfalene, and sulfadimidine. The Nakamura crystallization model was shown to have a good prognostic ability, as it allows determination of the stability time profile of the drug systems prone to crystallization from the non-isothermal thermokinetic data.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Chemical Thermodynamics and Molecular Structure · Thermal and Kinetic Analysis · Analytical Chemistry and Chromatography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. R.J. Mcmahon, M.D. Ediger, T. Wu, L. Yu, S. Satija, Organic Glasses with Exceptional Thermodynamic and Kinetic Stability, in: D. Johnson (Ed.), 2007: pp. 98–101. 10.1039/9781847557919-00098.
2. Spray drying formulation of amorphous solid dispersions10.1016/j.addr.2015.12.010 ↗
3. Pharmaceutical applications of electrospraying10.1016/j.xphs.2016.04.024 ↗
4. M. Xu, P. Wan, S. Heng, C.V. Liew, Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor, (2015) 1–10. 10.1517/17425247.10.1517/17425247.2015.1054278 ↗
5. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – a comprehensive review10.1016/j.addr.2018.07.010 ↗
6. Yang · 2012 · 443
7. Microspheres based on a protein matrix and dipyridamole with possible inhalation administration10.1007/s11094-021-02519-5 ↗
8. Polymer-based nanoparticulate solid dispersions prepared by a modified electrospraying process10.4236/jbise.2011.412091 ↗
9. Preparation of controlled-release coevaporates of dipyridamole by loading neutral pellets in a fluidized-bed coating system10.1023/A:1016253119194 ↗
10. Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems10.1016/S0928-0987(03)00203-3 ↗
11. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process10.1016/j.ijpharm.2003.11.003 ↗
12. Amorphous solid dispersions: Rational selection of a manufacturing process10.1016/j.addr.2016.01.012 ↗
13. Pharmaceutical applications of powder-based binder jet 3D printing process – a review10.1016/j.addr.2021.113943 ↗
14. Microwave-induced in situ amorphization: a new strategy for tackling the stability issue of amorphous solid dispersions10.3390/pharmaceutics12070655 ↗
15. In vivo performance of innovative polyelectrolyte matrices for hot melt extrusion of amorphous drug systems10.1021/acs.molpharmaceut.0c00485 ↗
16. 3D Printing of medicines: engineering novel oral devices with unique design and drug release characteristics10.1021/acs.molpharmaceut.5b00510 ↗
17. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ10.1016/j.ijpharm.2017.01.035 ↗
18. Process monitoring of ultrasound compaction as a small-scale heating process10.1016/j.ejps.2013.06.001 ↗
19. Acid-catalyzed inversion of sucrose in the amorphous state at very low levels of residual water10.1023/A:1007517526245 ↗
20. Development, characterization and stabilization of amorphous form of a low Tg drug10.1016/j.powtec.2006.05.012 ↗
21. Amorphous active pharmaceutical ingredients in preclinical studies: preparation, characterization, and formulation10.2174/157340708786847852 ↗
22. A new DTA method for measuring critical cooling rate for glass formation10.1016/j.jnoncrysol.2005.03.029 ↗
23. A classification system to assess the crystallization tendency of organic molecules from undercooled melts10.1002/jps.22197 ↗
24. Nanocalorimetry measurements of metastable states10.1016/j.tca.2014.06.017 ↗
25. Glass forming ability of amorphous drugs investigated by continuous cooling and isothermal transformation10.1021/acs.molpharmaceut.6b00650 ↗
26. Near-infrared spectroscopic applications in pharmaceutical particle technology10.1080/03639045.2019.1641510 ↗
27. Applications of Fourier transform infrared spectroscopy to pharmaceutical preparations10.1080/17425247.2020.1737671 ↗
28. Uses of X-ray powder diffraction in the pharmaceutical industry
29. What are the important factors that influence API crystallization in miscible amorphous api–excipient mixtures during long-term storage in the glassy state?
30. Direct measurement of molecular mobility and crystallisation of amorphous pharmaceuticals using terahertz spectroscopy10.1016/j.addr.2015.12.021 ↗
31. Trends in analytical chemistry solid-state NMR spectroscopy in pharmaceutical sciences10.1016/j.trac.2020.116152 ↗
32. S. Sheokand, S.R. Modi, A.K. Bansal, Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly, (2014) 3364–3376. 10.1002/jps.24160.10.1002/jps.24160 ↗
33. Inverse gas chromatography applications : a review10.1016/j.cis.2014.07.002 ↗
34. The development of quasi-isothermal calorimetry for the measurement of drug–polymer miscibility and crystallization kinetics: olanzapine-loaded PLGA microparticles10.1021/acs.molpharmaceut.8b00364 ↗
35. Evaluation of amorphous solid dispersion properties using thermal analysis techniques10.1016/j.addr.2011.07.009 ↗
36. Kawakami · 2018
37. ICTAC kinetics committee recommendations for performing kinetic computations on thermal analysis data10.1016/j.tca.2011.03.034 ↗
38. ICTAC kinetics committee recommendations for collecting experimental thermal analysis data for kinetic computations10.1016/j.tca.2014.05.036 ↗
39. ICTAC kinetics committee recommendations for analysis of multi-step kinetics10.1016/j.tca.2020.178597 ↗
40. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: a case study with dipyridamole and cinnarizine10.1016/j.ejpb.2016.04.017 ↗
41. Kinetic stability of amorphous solid dispersions with high content of the drug: A fast scanning calorimetry investigation10.1016/j.ijpharm.2019.03.039 ↗
42. Effect of heating rate and kinetic model selection on activation energy of nonisothermal crystallization of amorphous felodipine10.1002/jps.24204 ↗
43. Crystallization kinetics of orthorhombic paracetamol from supercooled melts studied by non-isothermal DSC10.1080/03639045.2016.1236810 ↗
44. Crystallization kinetics of amorphous nifedipine studied by model-fitting and model-free approaches10.1002/jps.10425 ↗
45. Crystallization kinetics and glass-forming ability of rapidly crystallizing drugs studied by Fast Scanning Calorimetry10.1016/j.ijpharm.2021.120427 ↗
46. Kinetic stability of amorphous dipyridamole: a fast scanning calorimetry investigation10.1016/j.ijpharm.2019.118890 ↗
47. Computational pharmaceutics–a new paradigm of drug delivery10.1016/j.jconrel.2021.08.030 ↗
48. Molecular simulations in drug delivery: opportunities and challenges10.1002/wcms.1358 ↗
49. Long-term amorphous drug stability predictions using easily calculated, predicted, and measured parameters10.1021/acs.molpharmaceut.5b00409 ↗
50. Predictive simulation of bulk metallic glass crystallization during laser powder bed fusion
51. Kinetics of phase change. I: general theory10.1063/1.1750380 ↗
52. Kinetics of phase change. II Transformation-time relations for random distribution of nuclei10.1063/1.1750631 ↗
53. Granulation, phase change, and microstructure kinetics of phase change. III10.1063/1.1750872 ↗
54. Reaction kinetics in processes of nucleation and growth
55. To a statistical model of metal crystallization
56. I.S. Gutzow, J.W.P. Schmelzer, Kinetics of overall crystallization: kinetic criteria for glass-formation BT–the vitreous state: thermodynamics, structure, rheology, and crystallization, 2013. 10.1007/978-3-642-34633-0_10.10.1007/978-3-642-34633-0 ↗